Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CABA
#2358
Cabaletta Bio, Inc. - Common Stock
3.7
8
USD
+0.27%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.27%
Monthly Change
+35.97%
6 month change
+51.20%
Year Change
+98.95%
Previous Close
3.7
7
Open
3.7
8
Low
3.7
8
High
3.7
8
Volume
64
Markets
US Stock Market
Healthcare
CABA
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
19.39 M
24.61 M
27.58 M
46.38 M
50.74 M
111.32 M
163.05 M
Valuation ratios
Enterprise value
198.87 M
-12.4 M
213 M
875.8 M
-48.78 M
160.81 M
491.56 M
Price to earnings ratio
8.67
-2.11
-5.19
-13.43
-0.97
-1.04
-2.1
Price to sales ratio
—
—
—
—
-2 987.41
-486.76
-197.57
Price to cash flow ratio
10.79
2.86
5.95
16.94
1.27
-0.83
-0.39
Price to book ratio
2.64
0.83
2.64
3.84
0.74
0.97
0.09
Enterprise value to EBITDA ratio
—
—
—
—
0.4
-0.93
-2.55
Profitability ratios
Return on assets %
-0.29
-0.37
-0.45
-0.27
-0.63
-1.02
-0.29
Return on equity %
-0.3
-0.39
-0.51
-0.29
-0.76
-1.5
-0.42
Return on invested capital %
-6 602.77
-6 737.35
-2 623.97
-2 826.39
-2 699.03
-1 148.02
-302.03
Gross margin %
—
—
—
—
100
100
100
Operating margin %
—
—
—
—
329.32 K
76.55 K
233.14 K
EBITDA margin %
—
—
—
—
320.77 K
76.61 K
233.4 K
Net margin %
—
—
—
—
304.91 K
74.6 K
229.03 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
21.92
14.86
11.47
15.29
6.15
2.77
2.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
-0
-0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-1.16
-1.33
-1.58
-1.31
-1.78
-2.65
-9.66
EBIT per share
—
—
—
—
-2.53
-3.48
-15.45
EBITDA per share
—
—
—
—
-2.46
-3.48
-15.47
Total debt per share
—
—
—
—
—
—
—
Cash per share
4.69
4.75
3.63
5.89
3.31
2.7
1.04
Net current asset value per share
4.91
4.84
3.71
5.97
3.37
2.8
1.09
Tangible book value per share
3.79
3.92
3.2
5.53
3.05
2.24
0.92
Working capital per share
4.68
4.51
3.39
5.58
2.82
1.79
0.72
Book value per share
4.73
4.58
3.56
5.77
3.08
2.26
0.92
News
Is Cabaletta Bio (CABA) Stock Outpacing Its Medical Peers This Year?
Cabaletta Bio (CABA) Upgraded to Buy: Here's Why
Cabaletta Bio Q1 Earnings: More Positive Data Suggests CAR-T Can Work In Autoimmune (CABA)
Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY)
Cabaletta Bio (CABA) Upgraded to Buy: Here's What You Should Know
Are Medical Stocks Lagging Biodesix (BDSX) This Year?
Kyverna Stock: The King Of The CAR-T Autoimmune Revolution (NASDAQ:KYTX)
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?
What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now?
Cabaletta Bio: Do You Buy With The Insiders? (NASDAQ:CABA)
Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?
Guggenheim reiterates Buy rating on Cabaletta Bio stock, citing commercial plan